AVBP halted on Oct 6 2026 at $28.70
AVBP+0.8%on Tue Oct 6 2026
ArriVent BioPharma, Inc. Common Stock was up 0.8% on the day at $28.70, ranked #188 on — its usual five-minute volume, when TapeRank recorded this trading halt at 07:55 ET during the pre-market session when it was halted. TapeRank recorded 3 events for AVBP that day, between 07:55 and 08:34 ET, and each is in the timeline below.
THE DAY ON THE LIST · 3 EVENTS
- 07:55 ETHALT · PRE-MARKET
HALTED AT $28.70 · ▲ 0.8% ON THE DAY · — 5M RVOL · RANK #188
No verdict was committed for this event.
THE ROW AND SESSION LEVELS AT 07:55 ET
LAST28.70DAY▲ 0.8%5 MIN· 0.00%5M RVOL—5M $VOL—FLOAT*49.3MRANK#188SESSIONPRE-MARKETVWAP28.48HOD28.70LOD28.35OR HIGH—OR LOW—PREV CLOSE28.46PM HIGH28.70PM LOW28.35GAP▲ 0.84% (indicated)* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
— MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO
- 08:34 ETMOVER · PRE-MARKET
$10.49 · ▼ 63.1% ON THE DAY · 1198× 5M RVOL · RANK #1
JUSTIFIEDCONFIDENCE5/5AVBP fell 63.1% after ArriVent reported that its Phase 3 FURVENT trial missed the primary progression-free-survival endpoint. The failed pivotal trial materially undermines the lead program and supports a collapse of this magnitude.
WHYA 63.1% pre-market decline is severe, but proportionate to a disclosed Phase 3 primary-endpoint failure rather than an unexplained order-flow move.ANALYZED 08:34 ET · <1 MIN AGO · OPENAI/GPT-5.6-LUNATHE ROW AND SESSION LEVELS AT 08:34 ET
LAST10.49DAY▼ 63.1%5 MIN▼ 12.58%5M RVOL1198×5M $VOL$4.8MFLOAT*49.3MRANK#1SESSIONPRE-MARKETVWAP11.22HOD28.70LOD10.25OR HIGH—OR LOW—PREV CLOSE28.46PM HIGH28.70PM LOW10.25GAP▼ 63.14% (indicated)* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
— MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO
- 08:34 ETUNEXPLAINED MOVE · PRE-MARKET
$10.49 · ▼ 63.1% ON THE DAY · 1198× 5M RVOL · RANK #1
The same verdict as at 08:34 ET.
THE ROW AND SESSION LEVELS AT 08:34 ET
LAST10.49DAY▼ 63.1%5 MIN▼ 12.58%5M RVOL1198×5M $VOL$4.8MFLOAT*49.3MRANK#1SESSIONPRE-MARKETVWAP11.22HOD28.70LOD10.25OR HIGH—OR LOW—PREV CLOSE28.46PM HIGH28.70PM LOW10.25GAP▼ 63.14% (indicated)* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
— MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO
NO VERDICT MEANS THE MODEL HAD NOT REACHED THE NAME BEFORE THE EVENT WAS FINALIZED, OR ITS ANSWER HEDGED AND WAS WITHHELD. NOTHING WAS FILLED IN AFTERWARDS.
THE SESSION
- 07:55 ETHalted (T1); resumed 08:20 ET, after 25 minutes
- 09:30 ETOpened at $12.09, -57.5% on the previous close of $28.46
- 10:07 ETRegular-session low, $11.36
- 13:09 ETRegular-session high, $15.79
- 15:59 ETLast trade of the regular session, $15.14, -46.8% on the previous close of $28.46
- Volume: 16.1M shares in regular hours, 3.2M before the open
AVBP was halted at 07:55 ET at $28.70, then TapeRank recorded the stock at $10.49 by 08:34 ET after the halt resumed at 08:20 ET, marking a 63.1% decline. TapeRank’s read tied the move to ArriVent’s report that its Phase 3 FURVENT trial missed the primary progression-free-survival endpoint, materially undermining its lead program; no filing or news appeared in the prior 24 hours. The stock opened at $12.09, fell to $11.36 by 10:07 ET, then recovered to a $15.79 high at 13:09 ET before ending the regular session at $15.14.
WRITTEN THU OCT 15 2026 18:01 ET BY OPENAI/GPT-5.6-LUNA FROM THE FACTS ON THIS PAGE
FILINGS AND NEWS · 24H BEFORE THE MOVE
No SEC filings or wire news in the 24 hours before this was recorded. A move on news that never reached the wire shows nothing here, which is what UNEXPLAINED means.
On the tape right now
WHERE THE LIST STOODWED NOV 4 2026 · 13:49 ETRECORDED LIVE · 742 QUALIFY
Open the full list